| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |